GNQ Insilico Announces Collaboration with Fortune 100 Company to Develop Next-Generation Clinical Trial Platform
SAN FRANCISCO, CALIFORNIA, USA, March 4, 2024 /EINPresswire.com/ — GNQ Insilico Inc. (“GNQ”), a company developing a generative artificial intelligence and quantum computing platform to assist life sciences companies in conducting in silico clinical trials for drug discovery and drug development, is pleased to announce that it has commenced the development of the platform with […]
